GB Sciences, Inc. (GBLX)
0.0002
0.00 (0.00%)
USD |
OTCM |
Sep 17, 16:00
GB Sciences Free Cash Flow
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2024 | -0.5064M |
| September 30, 2024 | -0.5875M |
| June 30, 2024 | -0.8924M |
| March 31, 2024 | -0.9757M |
| December 31, 2023 | -0.9431M |
| September 30, 2023 | -1.138M |
| June 30, 2023 | -1.372M |
| March 31, 2023 | -1.558M |
| December 31, 2022 | -2.104M |
| September 30, 2022 | -2.132M |
| June 30, 2022 | -1.672M |
| March 31, 2022 | -2.066M |
| December 31, 2021 | -2.200M |
| September 30, 2021 | -3.138M |
| June 30, 2021 | -2.841M |
| March 31, 2021 | -2.478M |
| December 31, 2020 | -1.811M |
| September 30, 2020 | -2.904M |
| June 30, 2020 | -2.225M |
| March 31, 2020 | -4.790M |
| December 31, 2019 | -7.348M |
| September 30, 2019 | -6.909M |
| June 30, 2019 | -8.293M |
| March 31, 2019 | -11.55M |
| December 31, 2018 | -15.20M |
| Date | Value |
|---|---|
| September 30, 2018 | -16.65M |
| June 30, 2018 | -19.50M |
| March 31, 2018 | -15.68M |
| December 31, 2017 | -11.98M |
| September 30, 2017 | -10.63M |
| June 30, 2017 | -8.006M |
| March 31, 2017 | -7.521M |
| December 31, 2016 | -5.473M |
| September 30, 2016 | -4.769M |
| June 30, 2016 | -4.997M |
| March 31, 2016 | -4.446M |
| December 31, 2015 | -4.257M |
| September 30, 2015 | -4.268M |
| June 30, 2015 | -4.800M |
| March 31, 2015 | -4.483M |
| December 31, 2014 | -4.166M |
| September 30, 2014 | -2.744M |
| June 30, 2014 | -1.186M |
| March 31, 2014 | -0.2288M |
| December 31, 2013 | -0.0344M |
| September 30, 2013 | -0.0407M |
| June 30, 2013 | -0.0462M |
| March 31, 2013 | -0.0374M |
| December 31, 2012 | -0.0452M |
| September 30, 2012 | -0.0428M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cocrystal Pharma, Inc. | -8.276M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | -208.80M |
| Fulcrum Therapeutics, Inc. | -66.14M |
| Definium Therapeutics, Inc. | -166.74M |